Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
尾加压素Ⅱ与肾脏疾病的研究进展
( views:115, downloads:8 )
Author:
No author available
Journal Title:
JOURNAL OF MODERN CLINICAL MEDICAL BIOENGINEERING
Issue:
2
DOI:
10.3760/cma.j.issn.1008-634X.2007.02.018
Key Word:
No keyword available
Abstract: @@ 尾加压素Ⅱ(urotensinⅡ,UⅡ)是一种具有广泛生物学效应的血管活性肽.它最初是从鱼的脊髓尾垂体中分离出来的生长抑素样环肽[1].
Reference
[1]张勇刚,陈亚红,马春艳,等.
尾加压素Ⅱ的促丝裂作用
[J].2001,(1).
[2]Conlon J. Michael,Yano Kenji,Waugh David,etc.
Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates
[J].1996.
[3]Hayashi Y,Totsune K,Shibahara S,etc.
Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II.
[J].2003,24(2).
[4]Sergey V, Brodsky,Tokunori, Yamamoto,Tetsuhiro, Tada,etc.
Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells.
[J].2002,282(6).
[5]Imai T,Takasu N,Matsushita M,etc.
Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues.
[J].2001,19(12).
[6]Murakami O,Imai Y,Sone M,etc.
Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.
[J].2004,25(10).
[7]R S, Ames,H M, Sarau,J K, Chambers,etc.
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
[J].1999,401(6750).
[8]Conlon JM,Tostivint H,Vaudry H,etc.
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.
[J].1998,95(26).
[9]K, Totsune,K, Takahashi,Z, Arihara,etc.
Role of urotensin II in patients on dialysis.
[J].2001,358.
[10]David J, Behm,Christopher L, Herold,Eliot H, Ohlstein,etc.
Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist.
[J].2002,137(4).
[11]Robyn G, Langham,Darren J, Kelly,Renae M, Gow,etc.
Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
[J].2004,44(5).
[12]Cooper ME,Gilbert RE.
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
[J].1999,56(5).
[13]Balat A,Pakir IH,Gok F,etc.
Urotensin-II levels in children with minimal change nephrotic syndrome.
[J].2005,20(1).
[14]Celia Muller,Keith Morrison,ClausMuller,etc.
Pharmacology of the Urotensin-ll Receptor Antagonist Palosuran(ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt):First Demonstration of a Pathophysiological Role of the Urotensin System
[J].2004,311(1).
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn